Wednesday, Sep 18 2019 | Time 10:45 Hrs(IST)
image
  • Israeli Blue and White Bloc head says ready to 'speak with everyone' about Gov't formation
  • Trade pact headway may offer both US and India - a win-win situation
  • People deserve to know the truth about what happened to Netaji after air crash at Taihoku : Mamata
  • Israeli PM's challenger calls for unity gov't
  • Riyadh to present evidence of Iran's involvement in attacks on oil facilities on Wednesday
  • Trump to meet Imran
  • Pakistan condemns attack of Saudi's oil facility
  • Two more cases of Polio reported in Pakistan
  • All eyes on Mamata-Modi meet in capital on Wednesday
  • French experts to help Saudi Arabia investigate attacks on oil facilities
  • Low Pressure area likely to form in next 12 hrs under influence of cyclonic circulation : IMD
  • Ramanathan-Gengel move into doubles second round in Glassgow
  • Ramanathan-Gengel move into doubles second round in Glassgow
  • US Military leaders provided Trump with plan to attack Iran oil facilities - Reports
  • Momota, Chen Long advance into BWF China Open 2nd round
Business Economy


Dr Reddy's announces launch of Fosaprepitant for Injection in US Market

Dr Reddy's announces launch of Fosaprepitant for Injection in  US Market

Hyderabad, Sep 11 (UNI) Dr Reddy’s Laboratories Limited on Wednesday announced the launch of therapeutic generic equivalent of Emend (fosaprepitant) for injection, approved by the US Food and Drug Administration (USFDA).



“We are pleased to be among the first generics to launch this product,” explained Marc Kikuchi, Chief Executive Officer, North America Generics, Dr Reddy’s Laboratories.

“This is a great addition to our injectable portfolio in the US market as we continue to augment our product offering and drive growth for the hospital segment,” he said.



The Emend for Injection brand had an US sales of approximately USD 279 million MAT for the most recent twelve months ending in July 2019 according to IQVIA Health, a company statement here said .



Dr Reddy’s Fosaprepitant for Injection is available in 150 mg single-dose vial for reconstitution.

UNI VV CS 1625

More News
APEDA to hold Multi-Product Road Show in Indonesia

APEDA to hold Multi-Product Road Show in Indonesia

18 Sep 2019 | 9:32 AM

New Delhi, Sep 18 (UNI) The Agricultural and Processed Food Products Export Development Authority is organising a road show in Medan, Indonesia on Wednesday.

see more..

UP sugar industry worried over govt's decision to hike reserve quota of molasses

17 Sep 2019 | 8:14 PM

Lucknow, Sep 17 (UNI) Uttar Pradesh government's move to hike the reserved quota of molasses from 12.

see more..

Pradhan discusses developments in energy markets with Rosneft CEO Sechin

17 Sep 2019 | 8:11 PM

New Delhi, Sep 17 (UNI) Petroleum and Natural Gas Minister Dharmendra Pradhan discussed developments in energy markets, including global crude oil supplies, in the light of the recent attacks on Saudi Aramco’s facilities with Mr Igor Sechin, Chairman of the Management Board and CEO, Rosneft and Former Deputy Prime Minister of the Russian Federation here on Tuesday.

see more..

Kottayam-Kochi Rubber Market Rates

17 Sep 2019 | 5:37 PM

Kottayam, Sep 17(UNI) Following were the Rubber Market rates
announced by the Rubber Board here today per quintal
KOTTAYAM
RSS FOUR Rs 13300
RSS FIVE Rs 12900
ISNR TWENTY: Rs.

see more..
Lenovo launches AI-enabled ThinkPad, ThinkCentre PC's

Lenovo launches AI-enabled ThinkPad, ThinkCentre PC's

17 Sep 2019 | 5:32 PM

New Delhi, Sep 17 (UNI) Tech major Lenovo on Tuesday launched the new Artificial Intelligence (AI)-enabled ThinkPad and ThinkCentre PCs and announced its foray into commercial IoT and security solutions.

see more..
image